gliclazide has been researched along with Mouth Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cirillo, N; Gasparoto, TH; Hassona, Y; Morgan, DJ; Pignatelli, M; Prime, SS | 1 |
Kowsalya, R; Manoharan, S; Vishwanathan, P | 1 |
2 other study(ies) available for gliclazide and Mouth Neoplasms
Article | Year |
---|---|
Characterization of a novel oral glucocorticoid system and its possible role in disease.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Acantholysis; Adrenocorticotropic Hormone; Anti-Inflammatory Agents; Carcinoma, Mucoepidermoid; Carcinoma, Squamous Cell; Cells, Cultured; Epithelial Cells; Fibroblasts; Glucocorticoids; Glycyrrhetinic Acid; Humans; Hydrocortisone; Mouth Mucosa; Mouth Neoplasms; Pemphigus; Receptor, Melanocortin, Type 2; Receptors, Glucocorticoid; Salivary Glands | 2012 |
Chemopreventive potential of 18beta-glycyrrhetinic acid: an active constituent of liquorice, in 7,12-dimethylbenz(a)anthracene induced hamster buccal pouch carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Carcinogens; Carcinoma, Squamous Cell; Cheek; Cricetinae; Glycyrrhetinic Acid; Glycyrrhiza; Humans; Liver; Male; Mesocricetus; Mouth Neoplasms | 2011 |